Hhlr Advisors, Ltd. Regenxbio Inc. Transaction History

Hhlr Advisors, Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$24.62 - $34.31 $11.2 Million - $15.6 Million	-456,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$31.84 - $50.88 $7.96 Million - $12.7 Million	250,000 Added 121.36%	456,000 $16.2 Million
Q2 2019 Aug 14, 2019	BUY	$42.0 - $59.29 $8.65 Million - $12.2 Million	206,000 New	206,000 $10.6 Million

187

43.1M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $355M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Hhlr Advisors, Ltd., based on Form 13F filings with the SEC.

Stay updated on Hhlr Advisors, Ltd. with notifications on news.